Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation

Cancer

Volumn 120, Issue 9, 2014, Pages 1426-1432

  Tseng, Jennifer ^a   Citrin, Deborah E ^a   Waldman, Meryl ^b   White, Donald E ^a   Rosenberg, Steven A ^a   Yang, James C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

adopted cell therapy; autologous T cell therapy; immunotherapy; metastatic melanoma; thrombotic microangiopathy; total body irradiation; tumor infiltrating lymphocytes

Indexed keywords

ACETAZOLAMIDE; AMLODIPINE; CD34 ANTIGEN; CLONIDINE; CREATININE; CYCLOPHOSPHAMIDE; FLUDARABINE; FUROSEMIDE; HAPTOGLOBIN; HYDROCHLOROTHIAZIDE; LABETALOL; LACTATE DEHYDROGENASE; LISINOPRIL; LOSARTAN; METOPROLOL; RECOMBINANT INTERLEUKIN 2; SPIRONOLACTONE;

ADOPTIVE TRANSFER; ADULT; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CHEMORADIOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CONTROL; DISEASE MARKER; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INCIDENCE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; METASTATIC MELANOMA; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETICULOCYTE COUNT; SURVIVAL RATE; SYSTEMIC THERAPY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR ASSOCIATED LEUKOCYTE; WHOLE BODY RADIATION;

ADOPTED CELL THERAPY; AUTOLOGOUS T CELL THERAPY; IMMUNOTHERAPY; METASTATIC MELANOMA; THROMBOTIC MICROANGIOPATHY; TOTAL BODY IRRADIATION; TUMOR INFILTRATING LYMPHOCYTES;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MIDDLE AGED; PILOT PROJECTS; RADIATION INJURIES; RECOMBINANT PROTEINS; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME; VIDARABINE; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 84899481184     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28547     Document Type: Article

References (26)

1. Rosenberg SA, Yannelli JR, Yang JC, et al. Treatment of patients with metastatic melanoma using autologous tumor-infiltrating lymphocytes and interleukin-2. J Natl Cancer Inst. 1994; 86: 1159-1166.
2. Wrzesinski C, Paulos CM, Kaiser A, et al. Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells. J Immunother. 2010; 33: 1-7.
3. Dudley ME, Yang JC, Sherry RM, et al. Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008; 26: 5233-5239.
4. Rosenberg SA, Yang JC, Sherry RM, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res. 2011; 17: 4550-4557.
5. Kal HB, van Kempen-Harteveld ML,. Renal dysfunction after total body irradiation: dose-effect relationship. Int J Radiat Oncol Biol Phys. 2006; 65: 1228-1232.
6. Rabinowe SN, Soiffer RJ, Tarbell NJ, et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood. 1991; 77: 1837-1844.
7. Krochak RJ, Baker DG,. Radiation nephritis. Clinical manifestations and pathophysiologic mechanisms. Urology. 1986; 27: 389-393.
8. Miralbell R, Bieri S, Mermillod B, et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol. 1996; 14: 579-585.
9. Casarett GW,. Histopathology of alpha radiation from internally administered polonium. Atomic Energy Commission Report UR-201. Rochester, NY: University of Rochester; 1952.
10. Cogan MG, Arieff AI,. Radiation nephritis and intravascular coagulation. Clin Nephrol. 1978; 10: 74-78.
11. Laskin BL, Goebel J, Davies SM, Jodele S,. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011; 118: 1452-1462.
12. Cheng JC, Schultheiss TE, Wong JY,. Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation. Int J Radiat Oncol Biol Phys. 2008; 71: 1436-1443.
13. Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR,. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol. 2009; 4: 345-353.
14. Keane WF, Crosson JT, Staley NA, Anderson WR, Shapiro FL,. Radiation-induced renal disease. A clinicopathologic study. Am J Med. 1976; 60: 127-137.
15. Cassady JR,. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995; 31: 1249-1256.
16. Tarbell NJ, Guinan EC, Niemeyer C, Mauch P, Sallan SE, Weinstein HJ,. Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys. 1988; 15: 99-104.
17. Hsiu-San L, Drzymala R,. Principles and Practice of Radiation Oncology. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 1997.
18. Chou RH, Wong GB, Kramer JH, et al. Toxicities of total-body irradiation for pediatric bone marrow transplantation. Int J Radiat Oncol Biol Phys. 1996; 34: 843-851.
19. McGinn CJ, Shewach DS, Lawrence TS,. Radiosensitizing nucleosides. J Natl Cancer Inst. 1996; 88: 1193-1203.
20. Lawton CA, Barber-Derus SW, Murray KJ, Cohen EP, Ash RC, Moulder JE,. Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients. Int J Radiat Oncol Biol Phys. 1992; 23: 681-686.
21. Delgado J, Cooper N, Thomson K, et al. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006; 12: 75-83.
22. Grégoire V, Van NT, Stephens, LC, et al. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. Cancer Res. 1994; 54: 6201-6209.
23. Moulder JE, Cohen EP, Fish BL,. Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation. Radiat Res. 2011; 175: 29-36.
24. Cohen EP, Joines MM, Moulder JE,. Prevention and treatment of radiation injuries: the role of the renin-angiotensin system. In:, Rubin P,;, Constine LS, Mark LB, Okunieff P, editors. Late Effects of Cancer Treatment on Normal Tissues. Heidelberg, Germany: Springer-Verlag; 2008: 69-76.
25. Juckett MB, Cohen EP, Keever-Taylor CA, et al. Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors. Bone Marrow Transplant. 2001: 451-456.
26. Moulder JE, Fish BL, Cohen EP,. ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. Curr Pharm Des. 2003; 9: 737-749.